|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 339.55 CHF | +2.15% |
|
-4.53% | +3.38% |
| 09:14am | Swiss stocks - Factors to watch on March 10 | RE |
| 03-10 | Roche Provides Update On Phase III Persevera Study In Er-Positive Advanced Breast Cancer | CI |
| Capitalization | 266B 341B 294B 255B 463B 31,427B 484B 3,137B 1,258B 15,033B 1,281B 1,253B 53,949B | P/E ratio 2026 * |
17.9x | P/E ratio 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise value | 274B 352B 304B 263B 477B 32,421B 499B 3,236B 1,298B 15,509B 1,321B 1,293B 55,656B | EV / Sales 2026 * |
4.36x | EV / Sales 2027 * | 4.1x |
| Free-Float |
87.84% | Yield 2026 * |
3.02% | Yield 2027 * | 3.11% |
Last Transcript: Roche Holding AG
| 1 day | +2.17% | ||
| 1 week | -4.53% | ||
| Current month | -7.55% | ||
| 1 month | -3.36% | ||
| 3 months | +5.37% | ||
| 6 months | +27.51% | ||
| Current year | +3.38% |
| 1 week | 315.6 |  | 364.1 |
| 1 month | 315.6 | | 374.9 |
| Current year | 315.6 | | 374.9 |
| 1 year | 231.9 | | 374.9 |
| 3 years | 212.9 | | 374.9 |
| 5 years | 212.9 | | 404.2 |
| 10 years | 206.35 | | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 15/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 06/06/2011 |
Wafaa Mamilli
CTO | Chief Tech/Sci/R&D Officer | 59 | 10/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 67 | 01/01/1996 |
Severin Schwan
CHM | Chairman | 59 | 15/03/2023 |
| Director/Board Member | 73 | 03/03/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 9.03% | 121 M€ | |
| -1.92% | 8.46% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.15% | -4.53% | +10.38% | +28.69% | 341B | |
| +1.82% | -0.94% | +15.96% | +218.25% | 901B | |
| +0.91% | -2.40% | +45.53% | +60.40% | 585B | |
| -1.16% | -2.91% | +6.14% | +54.36% | 402B | |
| +1.52% | -2.47% | +21.60% | +65.21% | 307B | |
| +2.23% | -1.07% | +24.74% | +38.08% | 300B | |
| +1.14% | -3.54% | +23.73% | +8.84% | 290B | |
| +2.01% | -2.26% | +16.04% | +66.96% | 203B | |
| +1.88% | -2.27% | +24.89% | +85.73% | 182B | |
| -0.37% | +9.76% | -53.75% | -49.16% | 175B | |
| Average | +1.06% | -2.44% | +13.53% | +57.74% | 368.59B | |
| Weighted average by Cap. | +0.86% | -2.61% | +17.99% | +86.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.81B 80.63B 69.56B 60.2B 109B 7,429B 114B 742B 297B 3,554B 303B 296B 12,752B | 65.14B 83.62B 72.13B 62.42B 113B 7,704B 119B 769B 308B 3,685B 314B 307B 13,224B |
| Net income | 14.52B 18.65B 16.08B 13.92B 25.3B 1,718B 26.45B 171B 68.76B 822B 69.99B 68.49B 2,949B | 15.72B 20.18B 17.41B 15.06B 27.38B 1,859B 28.63B 186B 74.42B 889B 75.75B 74.12B 3,191B |
| Net Debt | 8.41B 10.79B 9.31B 8.06B 14.64B 994B 15.31B 99.26B 39.81B 476B 40.52B 39.65B 1,707B | 1.29B 1.65B 1.43B 1.24B 2.25B 152B 2.35B 15.22B 6.1B 72.92B 6.21B 6.08B 262B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/03/26 | 339.30 CHF | +2.08% | 199,434 |
| 09/03/26 | 332.40 CHF | -2.58% | 2,266,833 |
| 06/03/26 | 341.20 CHF | -2.93% | 1,339,562 |
| 05/03/26 | 351.50 CHF | -2.03% | 1,087,503 |
| 04/03/26 | 358.80 CHF | +0.96% | 961,103 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition